Myth-buster
Lactobacillus casei failed to improve bladder cancer recurrence-free survival in a meta-analysis — no benefit over standard care.
This is among the first systematic reviews on this specific pairing, so the null result doesn't settle the question — but it provides the strongest evidence yet that L. casei alone may not reduce recurrence.
In a meta-analysis of nonintravesical interventions for non-muscle-invasive bladder cancer, adding Lactobacillus casei to standard therapy did not significantly prolong how long patients went without a recurrence. The analysis also found that a Western diet pattern worsened outcomes, but no benefit from other non-drug approaches. Because the evidence base is still thin, the role of probiotics in bladder cancer remains uncertain.
Where this fits in the evidence
This is among the first studies we've indexed on Lactobacillus casei for Improved Intravesical Recurrence-Free Survival — treat it as an early signal until more research accumulates.
The study
- Meta-Analysis
- 2025-04
- Clinical genitourinary cancer
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.